| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 09, 2025 | May 13, 2025 | Hickey Benjamin Pres RayzeBio Org. | Sell | Bristol Myers Squibb Co | BMY | $38.01 | $3,702 | -1.09% |
| Jan 16, 2024 | Jan 18, 2024 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $59.02 | $94,255 | -1.35% |
| Jan 08, 2024 | Jan 09, 2024 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $58.92 | $123,143 | -1.73% |
| Dec 13, 2023 | Dec 14, 2023 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $56.67 | $125,807 | -2.10% |
| Jan 17, 2023 | Jan 19, 2023 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $42.38 | $66,366 | -3.21% |
| Jan 09, 2023 | Jan 10, 2023 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $45.37 | $94,733 | -4.10% |
| Dec 21, 2022 | Dec 22, 2022 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $40.41 | $131,266 | -6.00% |
| Jan 18, 2022 | Jan 19, 2022 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $120.48 | $75,543 | -1.76% |
| Jan 07, 2022 | Jan 08, 2022 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $135.94 | $266,984 | -7.33% |
| Mar 19, 2021 | Mar 22, 2021 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $176.44 | $417,978 | -8.12% |
| Jan 07, 2021 | Jan 09, 2021 | Hickey Benjamin EVP Chief Commercial Officer | Sell | Mirati Therapeutics, Inc. | MRTX | $216.33 | $449,525 | -9.50% |